Markedly increased circulating concentrations of pyridoxal-5'-phosphate (PLP) 
that the majority of circulating PLP is of hepatic origin (2) . PLP is synthesized in the liver from pyridoxine, pyridoxal, and pyridoxamine, and then released into the blood where it circulates largely bound to albumin. Albumin-bound PLP does not appear to cross cell membranes directly; instead, the circulating PLP-albumin complex acts as a reservoir for pyridoxal which can enter cells once formed by hydrolysis of small quantities of free circulating PLP (2) . Ultimately, intracellular PLP is metabolized largely to 4-pyridoxic acid, which is then excreted in urine (3) . We 
Methods
Fourteen patients from 10 families with hypophosphatasia were studied (Table I ). 13 subjects are followed by one of us (Dr. Whyte) ) and one boy (R.J.) had no radiographic and/or no biopsy evidence of rickets or osteomalacia, but manifested the dental abnormalities of hypophosphatasia, i.e., odontohypophosphatasia (13) . Four of the patients with adult hypophosphatasia were from two kindreds which we have reported in detail (14, 15) . Plasma (heparinized blood) and serum were obtained, after an overnight fast, from the patients with hypophosphatasia, three normal subjects, and two control patients with a different form ofosteomalaciahypophosphatemic bone disease. None ofthese subjects had an unusual diet or were taking vitamin preparations or pharmaceuticals known to affect vitamin B6 nutrition or metabolism. Specimens were frozen within I h of venipuncture and, within 2 wk, were thawed and promptly assayed. Serum AP 
Results
Markedly increased plasma PLP levels were found in all subjects with hypophosphatasia ( Table I) . The average PLP concentration in patients was 1174 nM (range, 214-3839 nM), which was 21-fold greater than the average value for 38 normal adults (mean±SD, 57±26 nM) (16) . The two patients with the severe infantile form of hypophosphatasia appeared to have, on average, the greatest plasma PLP concentration (52-fold greater than normal). The lowest plasma PLP concentration (214 nM) was in a child with odontohypophosphatasia. The three normal subjects had unremarkable plasma PLP levels, whereas plasma PLP levels in the two hyperphosphatasemic control patients with hypophosphatemic rickets or osteomalacia were undetectable (<20 nM). Pyridoxine-5'-phosphate was not detected in any patient or control sample. With the exception of S.S., only traces of pyridoxine, pyridoxamine, and pyridoxamine-5'-phosphate were detected in plasma. Plasma concentrations of pyridoxal and 4-pyridoxic acid were mildly elevated in some patients (Table I) .
Increased plasma PLP levels were confirmed by the tyrosine apodecarboxylase method in the first four patient samples studied ( Table I ). The correlation coefficient for the plasma PLP concentrations determined by the cation exchange/HPLC vs. enzymatic methods was +0.99 for these four patient and two control samples.
Filtration studies revealed that, even with plasma PLP concentrations as great as 3053 nM in hypophosphatasia, >90% of the circulating PLP was protein-bound in both patient and control subjects (Table II) .
Elevated circulating PLP levels (of similar magnitude) were observed in each of the four patients with hypophosphatasia in whom assays were performed at 4-11 mo after the initial studies (Table I) . Urinary levels of 4-pyridoxic acid were unremarkable (3) in four affected children while they received diets containing recommended daily allowances of vitamin B6 (Table III) .
Discussion
AP is a ubiquitous plasma membrane-bound enzyme whose physiological role remains poorly defined despite intensive investigation (19) . Biochemical studies, including amino acid sequence analysis of both partial proteolytic peptide digests and NH2-terminal regions of AP purified from normal human tissues, suggest that three isoenzymes, each coded by separate genes, occur in man (20) . They have been generally referred to as placental, intestinal, and tissue nonspecific (bone/liver/ kidney) AP. Posttranslational modifications account for the well-documented physiocochemical differences in the tissue nonspecific AP family; bone, liver, and kidney AP are, therefore, secondary isoenzymes (19) . Study of the inborn error hypophosphatasia has resulted in the confirmation of the biochemical studies which indicate that at least three AP isoenzymes are present in man and in, perhaps, the best insight into the physiological role of AP ( 12). In the severe (autosomal recessive) infantile form, autopsy studies have revealed profound deficiency of AP activity in bone, liver, and kidney, but normal AP activity in intestine and placenta (fetal trophoblast). In the milder childhood and adult forms, which may be transmitted as an autosomal dominant trait, it has been suggested that the disorder represents clinical expression in heterozygous subjects (14) (15) (12, 19) .
Our findings support a variety of evidence that AP acts in the metabolism of vitamin B6 (2, (4) (5) (6) (7) (8) (9) (10) (11) . In vitro, PLP has been shown to be hydrolyzed by leukocyte subcellular organelles which are rich in AP activity (6) , and an inverse relationship has been reported between the PLP concentration and AP activity in leukocytes from normal subjects compared with patients with Down's syndrome (4) . Furthermore, AP purified from rat liver plasma membranes has been shown to hydrolyze PLP (5) . In vivo, circulating PLP concentrations have been found to be reduced in patients with a variety of disorders associated with increased circulating AP activity, especially hepatic diseases and malignancy (8-1 1 
